NeuroPace (NPCE) Net Margin Growth (1y) (2021 - 2026)
NeuroPace (NPCE) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 67.00 |
| 10 | NeuroPace | 469.45 Mn | 417.75 Mn | 18.91 Mn | 1,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,044.00 |
| Dec 31, 2025 | 2,510.00 |
| Sep 30, 2025 | 879.00 |
| Jun 30, 2025 | -5,355.00 |
| Mar 31, 2025 | 2,066.00 |
| Dec 31, 2024 | -2,148.00 |
| Sep 30, 2024 | 1,786.00 |
| Jun 30, 2024 | 1,618.00 |
| Mar 31, 2024 | 1,629.00 |
| Dec 31, 2023 | 7,266.00 |
| Sep 30, 2023 | 5,983.00 |
| Jun 30, 2023 | 6,758.00 |
| Mar 31, 2023 | 3,469.00 |
| Dec 31, 2022 | 1,164.00 |
| Sep 30, 2022 | -2,798.00 |
| Jun 30, 2022 | -7,308.00 |
| Mar 31, 2022 | -4,995.00 |
| Dec 31, 2021 | 34,134.00 |
| Sep 30, 2021 | -4,574.00 |
| Jun 30, 2021 | 4,451.00 |